Find your next paid study

Vertex Pharmaceuticals IncorporatedNCT07868926

~$500 – $10,500

Actual pay is set by the research site.

Phase 1

A Phase I Randomised, Single-blind, Placebo-controlled Study to Assess the Safety, Tolerability, and Pharmacokinetics of AZD1613 Following Multiple Ascending Dose Administration in Participants With Autosomal Dominant Polycystic Kidney Disease

A study to investigate safety, tolerability, and pharmacokinetics of AZD1613 following subcutaneous or intravenous administration in participants with autosoma…

Autosomal Dominant Polycystic Kidney Disease (ADPKD)

~$150 – $4,500

Actual pay is set by the research site.

AstraZenecaNCT07228364

Observational

Short-Term Metabolic Impacts of Ren-Nu: A Dietary Program for Individuals With Polycystic Kidney Disease

This is a 16 week pilot study of the impact of a nutritionist led ketogenic diet (Ren-Nu) supplemented with the medical food KetoCitra on autosomal dominant po…

Richard FaticaNCT07454174

~$10 – $1,125

Actual pay is set by the research site.

Observational

Di-PKD: A Pilot Trial of a 12-Month Targeted Dietary Intervention on Cyst Progression in Patients With Autosomal Dominant Polycystic Kidney Disease

The goal of this interventional study is to evaluate the impact of a specific diet (low salt, limited caffeine, high potassium, low phosphate, limited protein,…

Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Loma Linda UniversityNCT06786260

Actual pay is set by the research site.

Characterization of the Nrf2 Response in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD)

The purpose of this study is to characterize oxidative stress and the Nrf2 antioxidant response in early stages of Autosomal Dominant Polycystic Kidney Disease…

Actual pay is set by the research site.

Mayo ClinicNCT04344769

Phase 2

A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of ABBV-CLS-628 in Adult Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Autosomal Dominant Polycystic Kidney Disease (ADPKD) is the most common genetic cause of kidney disease that causes fluid-filled cysts to develop in the kidney…

Calico Life Sciences LLCNCT06902558

~$75 – $2,800

Actual pay is set by the research site.

Observational

A Pilot Study for Managing Depressive Symptoms in Autosomal Dominant Polycystic Kidney Disease (ADPKD)

The purpose of this research is to evaluate the feasibility and effectiveness of Digital Neurotherapy (DNT) or Capacity Coaching (CC) for managing symptoms of …

ADPKD (Autosomal Dominant Polycystic Kidney Disease)

Actual pay is set by the research site.

Mayo ClinicNCT07745920

Phase 2

Bempedoic Acid Therapy for Polycystic Kidney Disease (BEAT-PKD) Randomized Clinical Trial

Autosomal dominant polycystic kidney disease (ADPKD), the most commonly inherited kidney disease, is characterized by the development of cysts in the kidney th…

Kenneth HallowsNCT07282821

~$75 – $3,000

Actual pay is set by the research site.

Autosomal Dominant Polycystic Kidney Disease Somatic Mutation Biorepository

This study will analyze the germline and somatic mutations underlying the development of ADPKD in order to better understand the genetic mechanism responsible …

Weill Medical College of Cornell UniversityNCT03901521

Actual pay is set by the research site.

NOX4, Mitochondria and Related Biomarkers in Autosomal Dominant Polycystic Kidney Disease

To determine the value of NOX4, markers of mitochondria injury and function, and oxidative stress as real-time biomarkers to assess disease severity in patient…